Hot Papers

Edited by: Neeraja Sankaran D.A. Geller, C.J. Lowenstein, R.A. Shapiro, A.K. Nussler, M. Di Silvio, S.C. Wang, D.K. Nakayama, R.L. Simmons, S.H. Snyder, T.R. Billiar, "Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes," Proceedings of the National Academy of Sciences, 90:3491-5, 1993. (Cited in 135 publications through March 1995) GROUNDWORK: Cloning the human gene for iNOS opens up avenues of therapy for a variety of diseases, says David Geller Comment

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Edited by: Neeraja Sankaran
D.A. Geller, C.J. Lowenstein, R.A. Shapiro, A.K. Nussler, M. Di Silvio, S.C. Wang, D.K. Nakayama, R.L. Simmons, S.H. Snyder, T.R. Billiar, "Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes," Proceedings of the National Academy of Sciences, 90:3491-5, 1993. (Cited in 135 publications through March 1995)


GROUNDWORK: Cloning the human gene for iNOS opens up avenues of therapy for a variety of diseases, says David Geller
Comments by David A. Geller, University of Pittsburgh

According to David A. Geller, a research assistant professor of surgery at the University of Pittsburgh School of Medicine, the cloning and expression of the gene described in this paper has garnered attention from the scientific community because of the biological importance of its product.

The protein--an inducible form of nitric oxide synthase (iNOS)--is responsible for the generation of nitric oxide (NO) from arginine. "NO mediates many important functions ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies